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Abstract
According to the data obtained in this experiment by means of the geldiffusion technique,
the specific antigen was not detected in MH134 ascitic tumor, comparing the anti-C3H liver sera
with anti-MH 134 tumor sera, though a loss of organ specific antigen and weak antigenicity were
found in MH134 tumor extract. In order to detect some qualitative alteration, supposedly a gain in
antigenic components, the transplant rejection test was carried out. The result of this test indicates
that the relative not absolute resistance could be induced to C3H mice by this prior sensitization
with cell free active extract eluted from MH134 tumor tissue by Fluorocarbon treatment. During
these experiments, it became clear that MH134 ascitic tumor cell has weak immunizing properties
so that prolonged lapse of time and large dose of antigen are inevitably necessary. Moreover,
through Fluorocarbon treatment of the tumor homogenate, the cellfree, serologically active antigen
could be obtained, which will serve well for the induction of the isologous immunization.
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It is known21 that the tumor cell contains various kinds of antigens such as
species-specificity, organ-specificity, blood group substances, histocompatibility
factors, and heterophile antigens of Forssman type. Antigens of various animal
tumors are studied by means of several immunological reactions, such as precipi-
tation, complement fixation, and anaphylaxis. In filtrable tumors some investi-
gators have successfully demonstrated the tumor specific antigenic substances
besides the virus antigen. In nonfiltable tumors, however, it is still disputable
whether the tumors do contain any specific antigens which are absent in the
tissue of the normal organism.
The present investigation is concerned with demonstration of antigenic
components of MH 134 ascitic hepatoma cells compared with antigenic compo-
nents of healthy C3H liver cells from which MH134 ascites tumor was originally
derived. With a view to demonstrate these antigenic components one group of
rabbits was immunized with extracts from MH134 ascitic tumor cells and another
group was with extracts from C3H liver cells. Immune rabbit-sera were com-
pared with each other by gel-diffusion technique in addition to absorption pro-
cedures with various homogenates. Moreover, to compensate the methodical
deficiencies of this technique, the transplant rejection test was applied on this
experiment in an attempt to verify the existence of antigen specific to MH 134
ascitic tumor.
As the result, the tumor specific antigen was not possible to detect in any
appreciable quantity from MH 134 ascitic tumor cell extracts by gel-diffusion
technique. However, the MH134 ascitic cancer cell proved to show a lowered
antigenicity together with loss of an antigenic component compared with those
of healthy C3H liver cells. The antigen obliterated in MH 134 tumor cells is
supposed to be organ-specific. As for the reason of the difficulty in detecting the
specific tumor antigen, it is assumed that the cancer cells have weak immuniz-
ing properties associased with its poor solubility so that it takes a longer period of
time and larger doses of antigens for rabbit to be immunized, compared with
the case of C3H liver cells. Though this method failed to detect the MH 134
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tumor specific antigen, it is reasonable to think that a gain or qualitative. alter-
nation of antigenic components is involved by the malignancy. According to the
transplant rejection test carried subsequently, inbred strain mice of C3H sen-
sitized with Fluorocarbon-treated MH 134 tumor extract prior to inoculaion of
viable MH 134 ascites cells showed resistance to the challenge of subsequent
inoculation of those cells, so that it is supposed that there exists a specific anti-
gen in the MH 134 tumor cells, distinct from that of original C3H liver cells.
This does not necessarily mean to be so-called MH 134 tumor specific antigen.
Moreover, isoantigen developed by repeated transplantations and residual
heterozygotes of the inbred strain might playa role of inducing the resistance in
pretreated C3H mice. However, these scanty data do not warrant the conclu-
sion on this point. Such studies along this line are still in progress.
MATEIALS AND METHODS
Mice, inbred C3H (Kyoto) were purchased from The Mouse Colony,
University Okayama. They weighed about 18,...,22 g at the start of experiments.
A strain of the MH 134 ascitic hepatoma (MH 134, in the 298th generat.)
was obtained by courtesy or Dr. MATSUMOTO, Takeda Laboratory, Osaka.
The tumor was kept in C3H mice of serial transfers. Transfers were done at
weekly intervals by i. p. inoculations of 5 X 106 washed tumor cells. Tumor
antigen was prepared from the MH 134 ascitic tumor homogenizing of fresh
material in buffered physiological saline (pH 7.5). The comparative study was
carried out between antigenic components of the MH 134 tumor cells and healthy
C3H liver tissue from which MH 134 ascitic hepatoma was originally derived.
Antigens were prepared either as whole homogenate or as the supernatant fluid
obtained by centrifugation of the homogenate at 3,000 r. p. m. Blood for control
serum was withdrawn from rabbits before injection of antigens. The antigen
mixed with Freund's adjuvant was injected into the two injection sites on the
back of rabbit; 6 rabbits were sensitized with the same tumor extract. Freund's
adjuvant was composed of the vigorous mixture of 1 ml of mineral oil,
0.5 ml of Arlacel A and 10 mg of dried, heat killed mycobacteria to 1 ml of
antigen solution (I.Omg N/ml). One week later, another injection of antigen
emulsified with above mentioned Freund's adjuvant was administered. There-
after, intravenous injection of antigen solution were repeatedly applied to the
rabbits as shown in Table 1. The total of the antigen-nitrogen amounts to
IOmg"'" 15mg. The blood was withdrawn at varying intervals thereafter for
the detection of precipitate antibody against the applied tumor extract. Ring tests
were done with the immunesera withdrawn, which were clarified by centrifuga-
tion at 3,000 r. p. m. for 30 min. The test was carried out in small test tubes
2
Acta Medica Okayama, Vol. 19 [1965], Iss. 1, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol19/iss1/4
Immunochemical Analysis of Antigenic Properties of MH134 Ascitic Hepatoma 43
Table 1 Immunization Procedure & Precipitate Reaction of Immune Rabbit Serum
against C3H Mice Liver Cell Extract
Day I
C3H mouse liver
I
Route of injection
I
Date of bleedingextract Nmg
1 1.0 1.M. (F. A) Bleeding
7 1.0 I.M. (F. A)
18 2.0 1. V.
20 1.0 1. V.
21 1.0 1. V.
22 1.0 1. V.
24 1.0 1. V.
25 1.0 1. V.
35 Bleeding
37 1.0 1. V. (precipitation (-))
38 1.0 1. V.
39 1.5 1. V.
40 1.0 1. V.
41 1.0 1. V.
51 Bleeding
52 1.5 1. V. (precipitation ( +))
53 1.5 1. V.
60 Bleeding
I
(precipitation (+ +))
(3 X 50mm), and a JX>sitive reaction usually occurred within a few minutes,
when the precipitation amounted at least to 1.0 rg of protein, showing a visible
turbidity ring of antigen-antibody complex at the interface of both solutions.
The preservation of the sera was achieved by freezing at-40°C, with adding
the merthiolate in a proportion of one part per 10,000. For the purpose of
analysis and identification of antigenic components, Ouchterlony's plate methodll
of gel-diffusion was employed. Preparation of diffusion plates was done as
described in the previous reJX>res. Before performance of the tests, quantitative
determination of equivalence zones of this system was performed according to
Heidelberger's method" for the purpose of obtaining equivalent antigen-antibody
reaction on the agar plate. Then, a series of small wells, geometrically placed
1 cm apart from one another in a layer of gel on a plate, are filled with solution
of diluted antigen solution (0.25 mn and immunesera (0.25 ml) arranged to
diffuse toward each other. Then precipitation was allowed to take place by
storing the plate in a humidified 37°C incubator, empirically set 3 to 7 days.
When the plate was fully developed, a drawing was made showing all the lines
that developed and a photograph taken, then the plate was stored in a cage
filled with formol gas. The antigenic solution used here was prepared by the
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centrifugation sedimentation of 3,000 r. p. m. of homogenized C3H liver tissue
and MHI 34 cancer tissue solution by grinding in Waring blender for 5 min and
Potter's homogenizer for another 5 min at 4°C. Further purification of the anti-
genic solution was made by the Fluorocarbon treatment, (which did not cause
any remarkable loss of antigenic components as far as precipitating tissue antigen
is concerned as shown in previous reporea.) Antisera were absorbed by
treating them with various dilutions of antigens (acetone powder of tissue homo-
genate) in test tubes for 1 hour at 37°C: the supernatant fluid by centrifugation
at 30,000 r. p. m. represented the absorbed antisera.
The methods in the transplant rejection test are described as follows. In
previous experiment, it was proved that the tumor specific antigen can be eluted
and purified from tumor homogenate by means of Fluorocarbon treatmenea•
Therefore, 0.6 mg N/ml of the antigenic solution thus treated was subcutaneously
injected divided two equal doses to inbred C3H mice, 6 mice in one group. The
dose for this sensitization (0.6 mg N) corresponds to the extract eluted by Fluoro-
carbon treatment of 5 X 109 tumor cells. Three weeks after the last sensitiza-
tion with the antigenic solution, viable MB134 ascitic tumor-cells were subcu-
taneously inoculated in axillar region of the pretreated C3B mice in a dose of
1 X 105 tumor cells which is sufficient in the number of cells, capable of 100 %
"take" of the MB 134 tumor transplant to inbred C3B mice according to the
data of T AKEDAJ9 • Another group of mice was inoculated with 5 X 106 tumor
cells. Since the tumor cells inoculated, "take" of tumor and the size of tumor
in diameter were measured and survival time of grafted mice was recorded in
each group of mice with control.
RESULTS
Preparation of Rabbit Antiserum Against MH 134 Tumor Extract
and C3H Liver Cell Extract: As mentioned in previous report, it took a
longer period of time and larger dose of antigen for rabbit to produce a suitable
antiserum against cancer cells than in the case of liver cells or serum. Therefore,
a combination of Freund's adjuvant method with the intravenous method was
employed for the preparation of the immune rabbit serum. The inoculation
schedule performed was shown in Table 1. By the time of the 7th weekend of
inoculation period suitable immuneserum were obtained. The total dose of
antigenic nitrogen amounted to about 10 mgN. Two out of 6 rabbits were well
immunized to this inoculation. Others did not respond so well to this inoculation.
On the other hand, in the case of inoculation with MH 134 tumor cell extract,
as shown in Table 2, the response of rabbit to this inoculation was not sufficient
by the time when the rabbit responded to C3B liver cells. It took over twice
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Table ~ Immunization Procedure & Precipitate Reaction of Immune Rabbit Serum
against MH 134 Tumor Cell Extract
Day I
MH134 tumor cell
I
Route of injection I Date of bleedingextract mgN
1 1.5 1. M. Bleeding
7 1.5 I.M.
10 0.6 I. V.
11 1.2 1. V.
20 1.0 1. V.
21 1.0 1. V.
25 1.5 1. V.
27 1.0 1. V.
30 1.5 1. V.
35 1.0 1. V.
45 Bleeding
49 0.6 1. V.
50 1.2 1. V.
60 Bleeding
62 0.3 1. V. (precipitation (-))
63 0.3 1. V.
65 0.6 1. V.
89 Bleeding
94 0.6 1. V. (precipitation (±))
95 1.2 1. V.
99 0.6 1. V.
100 0.6 1. V.
108 Bleeding
109 0.4 1. V. (precipitation (±))
110 0.4 1. V.
111 1.0 1. V.
I
120 Bleeding
(precipitation (+))
I
the period as compared with that of C3H liver cells. Even at the 18th weedend,
blood withdrawn from 3 of the 6 rabbits immunized showed no efficient response
to homologous tissue extract. Average dose of antigenic nitrogen was about
15 mg. In order to detect the antigenic difference between MH 134 tumor and
original C3H liver cells, these two were compared by gel-diffusion test on agar
plate, the results of which were described in text.
Analysis of the Antigenic Properties of MH 134 Extract compa1'ed
with C3H Liver Antigen by Cel-Diffusion Technique: The antigenic com-
ponents of C3H liver cell may be divided into several classes. General component
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which is found in all the tissues of C3H mouse, so-called species-specific antigen,
organ specific antigen, histocompatibility antigen, and heterogenous antigen. In
fact, the immune rabbit sera against C3H liver cells reacted with the homologous
antigen showing the several remarkable precipitating bands on the agar plates
(Fig. 1). This precipitin reaction was consisted of 3 main bands and a few
Fig. 1 AC=Anti-C3H
liver serum C=C3H
liver extract
®II@(ff
Fig. 2 M = MH134
tumor extract
@@
@(~®
®(@
Fig. 3 C-AC X 1=C3H
liver extract absorbed
with equivalent antj-C3H
liver serum
M-ACx2=MH134 tumor
extract
absorbed with 112 equiva-
lent anti-C3H liver serum
other weak lines, nearby the main bands, which did not always appear. These
precipitin bands mean that three main antigenic components are contained in
C3H liver cell. In contrast, the immuneserum against MH 134 tumor cells reacted
with the homologous antigen showing· not any remarkable precipitation bands
on the agar plates, as compared with those of C3H liver cell. This reaction was
consisted of 2 main bands. These two bands seem to be common in those of
C3H liver cell antigenic components by the fact that these lines are continuous
with each other (Fig. 2). As far as this experiment is concerned, the tumor
specific precipitin band was not detected in precipitin reactions on the gel-diffu-
sion plate, though depletion of one antigenic component has been demonstrated
in the gel-diffusion. Fig. 3 shows the precipitin reactions anti-C3H liver serum
absorbed by various dilutions of MH 134 tumor antigen and homologous C3H
liver antigen. The anti-C3H liver serum in the central well reacted with both
C3H liver antigen and MH 134 tumor antigen, producing continuous 2 chevron-
shaped lines, and one additional line only at the side on C3H liver antigen.
This indicates the presence of two common antigenic components, and one
component that is present in healthy C3H liver cell, but not present in MH 134
tumor cell. By adding the equivalent amount of C3H liver antigen, one precipi-
tation line located in between two main lines, which is absent in MH 134 cancer
antigen, was absorbed and disappeared on the plate. Whereas two other lines,
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which are common in MH 134 and C3H, have barely persisted to absorption
procedure with this amount of C3H liver antigen. The antigenic components of
MH134 might have immunologically, remarkably weak antigenicity compared
on the same nitaogen amount with those of C3H liver cells. It is assumed that
its antigenicity will be less than one third that of C3H liver cell antigen. How-
ever, the qualitative difference in antigenic patterns between NH 134 cancer
cells and original C3H liver cells could hardly be detected by means of the gel-
diffusion technique. The precipitin reactions between the anti-C3H liver serum
and various kinds of extracts from C3H mice organs such as spleen, kidney, and
serum were tried. Not any conclusive data were obtained in these comparisons
except for vague cross-reactions present in larger parts of precipitating bands
elicited by C3H liver extract, but a slight cross-reaction coincident to the band
which was absent in MH134 tumor extract. According to these results, the
antigenic component, which is absent in MH 134 cancer, will probably be organ-
specific antigen. Others belong to heteroantigens, and histocompatibility anti-
gens. In no case was it possible to remove all the C3H liver antigenic compo-
nents from anti-C3H serum by the absorption procedure with MH 134 extract.
The middle precipitating line supposed to be due to the organ specificity was
left unabsorbed even with inoculation with excess MHI 34 antigen (Fig. 4). The
Fluorocarbon-treated MH 134 tissue antigen
and original crude MH 134 antigen were
tested by serological reagent of anti-MH 134
rabbit serum. In this test, not any varia-
tion was found in the numbers of compo-
nents visualized on a gel-diffusion plate.
Therefore, the extract eluted by Fluoro-
carbon-treatment was supposed to be ade-
quate for the use as cell free, serologically
active material in the next experiment.
Attempts at Detecting MH 134 Cancer Specific Antigen by Means of
the Transplant Rejection Test: One group of 'six mice, 3 weeks after the
sensitization with Fluorocarbon-treated antigen 0.6mg N, was challenged with
subcutanous inoculation of 1 X 10~ MH 134 tumor cells. Another group was
challenged with 5 X 106 MH 134 tumor cells. Five out of 6 mice challenged with
1 X 10~ MH 134 cells showed the development of palpable tumor at the tumor
injection site by 10 days after inoculation; mean size of tumor at that time being
0.7 X 0.7. In the following 10--14 days the tumor has shrinked and finally
disappeared in 20--35 days after the tumor graft. One of them did not show
any formation of tumor mass. Two of them died from unknown cause at the
32nd day and 48th day while tumor still remained. All the mice of other group,
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inoculated with 5 X 106 tumor cells, were free of palpable tumor till the 7th day.
However, in the following 7 days a palpable tumor had developed at the site of
tumor injection with mean size of 1.2 X 1.2 and finally all the mice expired after
various survival times. Those mice that remained healthy, gradually gained
body weight as time passed, as shown in Fig. 5. The mice of control group
with inoculation of 5 X 106 showed development of palpable tumor at the site of
the tumor injection, by the 7th day after tumor graft; mean size of tumor at
that time being 1.2 X 1.2. These tumor-grafted mice have rapidly gained their
body weight for the first 10 days, along with the growth of inoculated tumor.
Thereafter they have gradually lost their body weight and finally expired as
shown in Fig. 5. Average survival time of control mice was 37 days. Next,
'30
-------.-=----..:.:..::_-_ __ .
~.
+
+
+
+
4 S" '1 ",••k
Fig.5 Body Weight & Survival Period of Inoculated Mice
+ indicate "expire" of control mouse
- nontreated C3R inoculated with 5 X 10 cells
.. - pretreated C3R inoculated with 1 X 10 cells
those mice that survived after rejection of the grafted tumor or without any
signs of tumor growth were challenged again with 5 X 106 MH 134 tumor cells.
Some of them developed MH 134 tumor within usual latent period. Not any
measurable prolongation of survival in other mice rechallenged was observed in
the present experiment. Average survival time was 41 days.
DISCUSSION
The techniques of tissue homogenization and differential centrifugation are
now widely used. However, ascitic tumor cells, such as MH 134 cancer cells
show tendency to resist successful homogenization by the methods in common
use, since the membrance and matrix of these cells are especially strong and
can not be ruptured by procedures designed for liver cellsl4• This fact appreciably
causes insolubility and irregularity of the tumor antigen coated with bulky mass
of host tissue. Undoubtedly, a large part of this lag in the immunization may
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be attributed to these characteristics of the tumor antigen used. In general, the
magnitude of the rise of antibodies and the period of immunization for suitable
antidody are reflected by the solubility of antigenic substance and its size related
to the solubility and moreover, by the amounts and the numbers of antigen
used. Consequently, a high concentration of suitable antibodies may well corres-
pond to a high concentration of the soluble antigen used for immunization of
animals. The lag of immunization period, found in the case of MH 134 tumor
as mentioned above, is supposedly due not only to this insolubility of antigen,
but far more due to the fact that MH 134 tumor tissue has scant amount and
number of antigenic components. Therefore, it took almost twice the immuniza-
tion time by the tumor antigen as compared with that by C3H liver antigen.
Substantial evidence has recently been provided to show the antigenic
differences between the normal cell and its tumor. The causes underlying these
differences may be quite differene l • Filterable tumors contain certain viruses
which penetrate into the cell from the outside and act as the etiologic factor of
the tumors, hence they may be called as tumor viruses. In spite of varying
degrees of association of the tumor viruses with normal cell components, these
viruses behave as antigenic foreign to the animal in which they induce tumors.
Non-filterable tumors can be classified into spontaneous tumor, induced
tumor, and transplanted tumors. In the present study, the antigen of transplated
MH 134 tumor was analysed by the gel-diffusion technique, while comparing
antibodies of immune rabbit sera against the MH 134 tumor tissue with anti-
bodies of immune rabbit sera against C3H liver cells from which the tumor
was originally derived. The study of antigens of transplantable tumors of any
origin involves some difficulties associated with the genotype differences between
the donor of the tumor and the recipient1• Most conclusive are experiments
carried out on inbred animals although in these cases prolonged passage of the
tumor might induce some modifications of its antigenic structure as detailed
later. The author failed to detect any specific antigen from MH 134 ascites
tumor by means of the gel-diffusion. However, it is still premature to conclude
by this result that there is no specific tumor antigen in the MH 134 tumor cell
distinct from C3H liver cell. As previously mentioned, the difficulty involved
in the detection of specific tumor antigen may be due to less numbers of these
antigens among the main bulk of tumor proteins indistinguishable from the
antigen of normal tissue. Probably the scarcity of specific antigens in tumor
tissue associated with poor solubility of them are also related to this difficulty
involved in the detection of them. In the gel-diffusion technique applied in this
experiment, the antigens should be soluhle and diffusable in an agar layer. This
is a serious limitation in the analysis of tumor antigens by such serological
method as gel-diffuaion technique6•
9
Tai: Immunochemical analysis of antigenic properties of MH134 ascitic
Produced by The Berkeley Electronic Press, 1965
50 C. TAl
As ZILBER'S experiment suggests the tumor antigen has generally a complex
structure. The major part of produced antibodies in rabbits immunized by the
MH 134 tumor tissue may belong to heteroantibodies against species specific
antigen and others, but not against organ specific antigen. As observed in the
present experiment, the antibody elicited by the organ specific antigen of C3H
liver did not react to MH134 tumor tissue extract. The metabolic disturbances
associated with the carcinogenic process may result in the loss of some antigens
from normal cells and peculiar simplification of their antigenic composition20•
The absence of organ specific antigen in MH 134 tumor tissue determined in
present study, is connected to this supposition. SELIGMAN21 has noted the simplifi-
cation of the antigenic structure in animal tumors. WEILER and VOGT20 have
also found that the antigen is lost in liver cancer of rats induced by feeding with
4-dimethyl aminoazobenzene and localized this antigen in the membrane of
endoplasmic reticulum. As the cells become malignant, a loss of some antigens
contained in normal cells may ensue10.16• Recently, FRIEDRICH-FRESKA3 et al. have
succeeded in purifying this tissue antigen of normal rat liver microsomes, which
is absent in induced liver cancer.
Now the question arises; Is there really any specific antigen in transplan-
table mouse tumor as a gain involved by malignant change? According to some
investigators21 , the specific antigen is to be found not only in the transplantable
hepatoma but also in that primarily induced by orthoaminoazotoluene. LEVlNA7
also has revealed in the hepatoma of mice an antigen which is absent from
healthy liver, by means of anaphylaxis following desensitization. In MACULLA'S21
experiments, the nucleoprotein fractions prepared after MINSKY and POLLISTER
(1942) from various transplantable mice tumors proved immunologically different
from those of normal mouse organs. This difference was found in a strictly
standardized test of complement fixation by the sera obtained through immuni-
zation of rabbits with various preparations from the tumor. However, these
results are not completely accepted with regard to the isoantigenicity between
the donor and the recipient of tumor. The alcohol extracts of various mouse
tumors obtained by other investigators2 are also antigenic substances, which
are specifically reacting components common to various mouse tumors. From
EHRLICH ascites mouse carcinoma and YOSHIDA ascitic rat sarcoma, an antigen
of a lipid character has been isolated by LUND21• The nature of antigens detected
in these studies is by no means certain. As a conclusion, the preparations
produced by a similar may from dif~erent transplantable tumors and tested in
different serological reactions naturally do not yield consistant results. The
antigens of cancerous and embryonic tissues were supposedly found to be closely
related in various transplantable mice tumors, especially similar to those of
embryonic liver although not all of them possessed adult liver components21 •
10
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MALMGREN9 stated that in serological analysis of microsomes from mouse hepa-
toma and normal liver, quantitative but no tumor specific differences were
observed. Consequently, it is reasonably supposed that MH 134 tumor antigen
is closely related to original C3H liver tissue antigen, so that the differentiation
of these antigens is a difficult problem. In the present study by the gel-diffusion
technique no antigan has been detected, that should be allocated only to the
11.H134 tumor cells, although a quantitative difference was noted in the reactivity
between the preparations from normal C3H liver tissue and that from MH 134
tumor, with loss of organ specificity of C3H liver. Therefore, the specific
MH 134 tumor antigen was viewed from the point of transplantation rejection
which would occur in pretreated C3H mice with homologous cell-free, serologi-
cally-active extracts of MH 134 tumor tissue. Formerlyli, it was not expected
that isologous immunity might be detected in such fully isologous system as C3H
liver cell and 11.H 134 ascitic tumor. Recently, many investigators12 have reported
the resistance that could be built up in autochthonous and isologous various
induced tumors and transplantable tumors. In such experiments for demonstrat-
ing the host resistance, the animals pretreated usually with heavy irradiated
antigenic solution6•13, were subsequently challenged with viable homologous
tumor cells. Whereas in the present 'experiment, Fluorocarbon treatment was
used instead of heavy irradiation. As in previous studies18, it is evident that this
treatment does not cause any measurable change in antigenic properties in as far
as the gel-diffusion is concerned. Namely, no qualitatjve difference in antigenic
patterns before and after this treatment does occur. The mechnism of the treat-
ment with Fluorocarbon is not clear but is supposed to purify the antigen in the
following procedure. The aggregates of antigens (virus antigen) and a ballast
protein of the tissue may be destroyed by treatment with a Fluorocarbon medium
which released pure antigen particles 10---20 mp. not sedimenting upon prolonged
centrifugation. According to LINDENMANN'S8 report, the removal of the bulk of
the tumor allowed the balance between the tumor and host to shift in favor of
the latter, and liberate otherwise inaccessible antigenic materials from the cells.
By the treatment of Fluorocarbon, also such effects might be suggested on the
tumor extracts. Four of the six C3H mice pretreated by MH 134 tumor extracts
(0.6 mg Nhreated by Fluorocarbon resisted subsequent challenge by 1 X 106 tumor
cells in various degrees. Fluorocarbon-treated 11.H 134 ascitic tumor tissue extract
can induce a state of resistance in isologous C3H mice of the highly inbred strain
from which 11.H 134 ascitic tumor was originally derived. \\lith the challenge
of 5 X 106 tumor cells, all those pretreated mice ultimately expired though mode-
rate retardation in latent period of "take" and prolonged survival time were
demonstrated. Resistance was relative rather than absolute and broken down
the dose of viable cell was incre1.sed. Although a few case5 of the control, C3H
11
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mice pretreated with C3H liver extract eluted through Fluorocarbon treatment
showed slight induced resistance, almost equal with nontreated control. Accord-
ing to KLEIN6, even isologous mice pretreated irradiated normal tissue and sub-
~equently challenged with viable tumor cells exhibited a moderate resistance,
which is considered to be the result of a nonspecific bolstering of the specific
immune response, provoked subsequently by the first challenge dose of viable
sarcoma cells. This fact means that the immune rabbit sera against MH 134
ascitic tumor contained the specific antibody to resist the graft or the growth of
the tumor subcutaneously inoculated into the inbred C3H mice. The MH 134
ascitic tumor thus has some specific antigen which is absent in original C3H
mice so that the Fluorocarbon-treated MH 134 tumor extract could induce a state
of resistance in isologous mice of C3H strain. Next, those mice that survived
after rejection of the grafted tumor were rechallenged by MH 134 ascitic tumor
cells expired even after a longer survival time than that of control. This fact
probably means the consuming of the induced resistance factor by previous
challenge of tumor cell. This experiment has been carried out on inbred animals
so the results might not have been due to isoantigenic differences between the
donor and the recipient of tumor. In such long-propagated tumor as this MH134
tumor, considerable genetic differential might be supposed to accumulate
through mutational changes in both tumor and hosts\ REVESZ1~, in his study,
has described that the isoantigenic differences that developed between a line of
inbred mice and its transplanted tumor, in serial passage through long periods
of time playa role to induce the resistant state in isologous host by the pretreat-
ment with irradiated tumor cells. Further, he has shown that no similar resis-
tance could be induced against lymphomas of recent origin. Taking these into
consideration, it is still premature to conclude that this rejection phenomenon of
tumor transplanted to the isologous animal pretreated with cell-free, serologically·
active extracts of homologous tumor tissue, is not attributed to mutation16 of the
tumor or host, namely, isoantigen, as caused by repeated transplantations or
residual heterozygotes14 of the inbred strain host but naturally attributed to anti-
bodies called forth to this tumor by means of the previous treatment with the
antigen solution. These still scanty data do not warrant the conclusion that
antigen of the MH 134 ascitic tumor, which is absent in healthy C3H liver cells,
is contained in tumor cells. Further study on this tumor is necessary. Especially,
additional control experiment is required. These studies are still in progress and
will be the subject of a separate report.
SUMMARY
According to the data obtained in this experiment by means of the gel-
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diffusion technique, the specific antigen was not detected in MH 134 ascitic
tumor, comparing the anti-C3H liver sera with anti-MH 134 tumor sera, though
a loss of organ specific antigen and weak antigenicity were found in MH 134
tumor extract. In order to detect some qualitative alteration, supposedly a gain
in antigenic components, the transplant rejection test was carried out. The result
of this test indicates that the relative not absolute resistance could be induced to
C3H mice by this prior sensitization with cell free active extract eluted from
MH 134 tumor tissue by Fluorocarbon treatment. During these experiments, it
became clear that MH 134 ascitic tumor cell has weak immunizing properties so
that prolonged lapse of time and large dose of antigen are inevitably necessary.
Moreover, through Fluorocarbon treatment of the tumor homogenate, the cell-
free, serologically active antigen could be obtained, which will serve well for
the induction of the isologous immunization.
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